Terms: = Pancreatic cancer AND ELN, ENSG00000049540, 2006, WS, WBS, SVAS, FLJ43523, FLJ38671 AND Treatment
400 results:
1. Prediction of disease recurrence in patients after complete pancreatic NET (PanNET) G2 resection.
Olearska H; Sowa-Staszczak A; Morawiec-Sławek K; Kurzyńska A; Kolasa M; Tkacz E; Szumińska M; Hubalewska-Dydejczyk A; Opalinska M
Endokrynol Pol; 2024; 75(1):102-108. PubMed ID: 38497396
[TBL] [Abstract] [Full Text] [Related]
2. A case report of cardia carcinoma: Underwent Heller myotomy for Achalasia.
Wen LQ; Wei DW
Medicine (Baltimore); 2024 Jan; 103(4):e36924. PubMed ID: 38277562
[TBL] [Abstract] [Full Text] [Related]
3. Contemporary Outcomes of Transduodenal Sphincteroplasty: the Importance of Surgical Quality.
Walia S; Zaidi MY; McGuire S; Milam C; Fogel EL; Sherman S; Lehman G; Pitt HA; Nakeeb A; Schmidt CM; House MG; Ceppa EP; Timsina L; Zyromski NJ
J Gastrointest Surg; 2023 Dec; 27(12):2885-2892. PubMed ID: 38062321
[TBL] [Abstract] [Full Text] [Related]
4. Fragmented care in localized pancreatic cancer: Is commission on cancer accreditation associated with improved overall survival?
Park SS; Verm RA; Abdelsattar ZM; Kramer S; Swanson J; Fernando M; Cohn T; Luchette FA; Baker MS
Surgery; 2024 Mar; 175(3):695-703. PubMed ID: 37863686
[TBL] [Abstract] [Full Text] [Related]
5. treatment Patterns and Outcomes in pancreatic cancer: A Comparative Analysis of Ontario and the USA.
Saadat LV; Schofield E; Bai X; Curry M; Saskin R; Lipitz-Snyderman A; Soares KC; Kingham TP; Jarnagin WR; D'Angelica MI; Wright FC; Irish JC; Coburn NG; Wei AC
Ann Surg Oncol; 2024 Jan; 31(1):58-65. PubMed ID: 37833463
[TBL] [Abstract] [Full Text] [Related]
6. Predictors and benefits of multiagent chemotherapy for pancreatic adenocarcinoma: Timing matters.
Valdera FA; O'Shea AE; Smolinsky TR; Carpenter EL; Adams AA; McCarthy PM; Tiwari A; Chick RC; Kemp-Bohan PM; Van Decar S; Thomas KK; Bader JO; Peoples GE; Clifton GT; Stojadinovic A; Nelson DW; Vreeland TJ
J Surg Oncol; 2024 Feb; 129(2):244-253. PubMed ID: 37800378
[TBL] [Abstract] [Full Text] [Related]
7. Impact of Preoperative Tumor Size on Prognosis of Resectable and Borderline Resectable pancreatic Ductal Adenocarcinomas.
Miyata Y; Yonamine N; Fujinuma I; Tsunenari T; Takihata Y; Hakoda H; Nakazawa A; Iwasaki T; Einama T; Togashi J; Tsujimoto H; Ueno H; Beck Y; Kishi Y
Ann Surg Oncol; 2023 Dec; 30(13):8621-8630. PubMed ID: 37658273
[TBL] [Abstract] [Full Text] [Related]
8. Palliative radiotherapy in pancreatic cancer: a retrospective study of 100 cases and regional patterns of practice.
Liu AKN; Lefresne S
Ann Palliat Med; 2023 Sep; 12(5):891-899. PubMed ID: 37574574
[TBL] [Abstract] [Full Text] [Related]
9. Association between Rural Residence and Processes of Care in pancreatic cancer treatment.
Amin K; Khan H; Hearld LR; Chu DI; Prete V; Mehari KR; Heslin MJ; Fonseca AL
J Gastrointest Surg; 2023 Oct; 27(10):2155-2165. PubMed ID: 37553515
[TBL] [Abstract] [Full Text] [Related]
10. Comparison of gemcitabine plus oxaliplatin versus gemcitabine plus nab-paclitaxel as first-line chemotherapy for advanced pancreatic adenocarcinoma: A single-center retrospective analysis.
Schlick K; Gantschnigg A; Seymer A; Huemer F; Greil R; Weiss L
Cancer Med; 2023 Aug; 12(16):16997-17004. PubMed ID: 37537780
[TBL] [Abstract] [Full Text] [Related]
11. Prognostic significance of ımmunhistochemical axl expression in pancreas ductal adenocarcinomas.
Oz O; Argon A; Kebat TA; Ozdemir O; Yakan S
Indian J Pathol Microbiol; 2023; 66(3):533-539. PubMed ID: 37530334
[TBL] [Abstract] [Full Text] [Related]
12. Trends in treatment patterns and survival outcomes in pancreatic cancer: A nationwide population-based study in Korea.
Park BK; Seo JH; Han JH; Lee KJ; Son KJ; Choi JK
Eur J Cancer; 2023 Aug; 189():112932. PubMed ID: 37352643
[TBL] [Abstract] [Full Text] [Related]
13. Bounding box-based 3D AI model for user-guided volumetric segmentation of pancreatic ductal adenocarcinoma on standard-of-care CTs.
Mukherjee S; Korfiatis P; Khasawneh H; Rajamohan N; Patra A; Suman G; Singh A; Thakkar J; Patnam NG; Trivedi KH; Karbhari A; Chari ST; Truty MJ; Halfdanarson TR; Bolan CW; Sandrasegaran K; Majumder S; Goenka AH
Pancreatology; 2023 Aug; 23(5):522-529. PubMed ID: 37296006
[TBL] [Abstract] [Full Text] [Related]
14. Clinical Practice Guidelines for pancreatic cancer 2022 from the Japan Pancreas Society: a synopsis.
Okusaka T; Nakamura M; Yoshida M; Kitano M; Ito Y; Mizuno N; Hanada K; Ozaka M; Morizane C; Takeyama Y;
Int J Clin Oncol; 2023 Apr; 28(4):493-511. PubMed ID: 36920680
[TBL] [Abstract] [Full Text] [Related]
15. Contemporary treatment Paradigms are Associated with Improved Survival in pancreatic cancer.
Kelly BN; Nicolais L; Mohamed A; Fitzgerald TL
Am Surg; 2023 Aug; 89(8):3390-3398. PubMed ID: 36872555
[TBL] [Abstract] [Full Text] [Related]
16. Disparities in NCCN Guideline-Compliant Care for Patients with Early-Stage pancreatic Adenocarcinoma at Minority-Serving versus Non-Minority-Serving Hospitals.
Lima HA; Alaimo L; Moazzam Z; Endo Y; Woldesenbet S; Katayama E; Munir MM; Shaikh C; Ruff SM; Dillhoff M; Beane J; Cloyd J; Ejaz A; Resende V; Pawlik TM
Ann Surg Oncol; 2023 Jul; 30(7):4363-4372. PubMed ID: 36800128
[TBL] [Abstract] [Full Text] [Related]
17. Volumetric Enhancing Tumor Burden at CT to Predict Survival Outcomes in Patients with Neuroendocrine Liver Metastases after Intra-arterial treatment.
Assouline J; Cannella R; Porrello G; de Mestier L; Dioguardi Burgio M; Raynaud L; Hentic O; Cros J; Tselikas L; Ruszniewski P; Vullierme MP; Vilgrain V; Duran R; Ronot M
Radiol Imaging Cancer; 2023 Jan; 5(1):e220051. PubMed ID: 36607243
[TBL] [Abstract] [Full Text] [Related]
18. Recent trends in the incidence and survival of stage I liver cancer: a surveillance, epidemiology, and end results analysis.
Yu XC; Liu JB; Tang QH; Diao X; Fan QY; Huang ZY; Tang XM; Li S; Cao YF; Ma YS; Fu D
Ann Med; 2022 Dec; 54(1):2785-2795. PubMed ID: 36370068
[TBL] [Abstract] [Full Text] [Related]
19. Prognostic Impact of Positive Peritoneal Lavage Cytology on Resectable pancreatic Body and Tail cancer: A Retrospective Study.
Mashiko T; Ogasawara T; Masuoka Y; Ei S; Takahashi S; Hirabayashi K; Mori M; Koyanagi K; Yamamoto S; Nakagohri T
World J Surg; 2023 Mar; 47(3):729-739. PubMed ID: 36357802
[TBL] [Abstract] [Full Text] [Related]
20. Decrease in Tumor Interstitial Pressure for Enhanced Drug Intratumoral Delivery and Synergistic Tumor Therapy.
Fu Y; Ye F; Zhang X; He Y; Li X; Tang Y; Wang J; Gao D
ACS Nano; 2022 Nov; 16(11):18376-18389. PubMed ID: 36355037
[TBL] [Abstract] [Full Text] [Related]
[Next]
